Invention Grant
- Patent Title: Compositions for oral administration of zoledronic acid or related compounds for treating low back pain
-
Application No.: US15897947Application Date: 2018-02-15
-
Publication No.: US10463682B2Publication Date: 2019-11-05
- Inventor: Herriot Tabuteau
- Applicant: ANTECIP BIOVENTURES II LLC
- Applicant Address: US NY New York
- Assignee: ANTECIP BIOVENTURES II LLC
- Current Assignee: ANTECIP BIOVENTURES II LLC
- Current Assignee Address: US NY New York
- Agency: Maschoff Brennan
- Agent Brent A. Johnson; Yuefen Zhou
- Main IPC: A61K31/675
- IPC: A61K31/675 ; A61K9/20 ; A61K47/12 ; A61K45/06 ; A61K9/28 ; A61K31/663 ; A61K9/00
Abstract:
Oral dosage forms of osteoclast inhibitors, such as zoledronic acid, in an acid form or a salt form, such as a disodium salt form, can be used to treat or alleviate pain or related conditions, such as low back pain.
Public/Granted literature
- US20180169119A1 COMPOSITIONS FOR ORAL ADMINISTRATION OF ZOLEDRONIC ACID OR RELATED COMPOUNDS FOR TREATING LOW BACK PAIN Public/Granted day:2018-06-21
Information query
